GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review
Open accessThe DOI matches its Crossref record; 454 of the 464 references it cites were found in a registry or an index; 60 of the 171 sources its claims cite were checked for support.
Abstract
Glycans are one of the four fundamental macromolecular components of living matter, and they are highly regulated in the cell. Their functions are metabolic, structural and modulatory. In particular, ER resident N-glycans participate with the Glc3Man9GlcNAc2 highly conserved sequence, in protein folding process, where the physiological balance between glycosylation/deglycosylation on the innermost glucose residue takes place, according GANAB/UGGT concentration ratio. However, under abnormal conditions, the cell adapts to the glucose availability by adopting an aerobic or anaerobic regimen of glycolysis, or to external stimuli through internal or external recognition patterns, so it responds to pathogenic noxa with unfolded protein response (UPR). UPR can affect Multiple Sclerosis (MS) and several neurological and metabolic diseases via the BiP stress sensor, resulting in ATF6, PERK and IRE1 activation. Furthermore, the abnormal GANAB expression has been observed in MS, systemic lupus erythematous, male germinal epithelium and predisposed highly replicating cells of the kidney tubules and bile ducts. The latter is the case of Polycystic Liver Disease (PCLD) and Polycystic Kidney Disease (PCKD), where genetically induced GANAB loss affects polycystin-1 (PC1) and polycystin-2 (PC2), resulting in altered protein quality control and cyst formation phenomenon. Our topics resume the role of glycans in cell physiology, highlighting the N-glycans one, as a substrate of GANAB, which is an emerging key molecule in MS and other human pathologies.
Overview
CoChat Summary
TL;DR
This review synthesizes glycobiology and the roles of GANAB/glucosidase II in ER N-glycan processing, unfolded protein response, and human disease. It highlights GANAB dysregulation in multiple sclerosis, polycystic liver/kidney disease, systemic lupus erythematosus, and other conditions, proposing GANAB as a biomarker and therapeutic target.
Key findings
- GANAB encodes the catalytic α-subunit of glucosidase II (GII), a heterodimer with the β-subunit PRKCSH; the human α-subunit is 944 amino acids with a 912-amino-acid catalytic domain (~103 kDa), and the β-subunit is 528 amino acids (~58 kDa). GII trims glucose residues from the Glc3Man9GlcNAc2 N-glycan in ER glycoprotein quality control.
- GANAB expression is highest in liver, followed by epididymis ductal cells, with kidney among top expression sites; abnormal GANAB expression is reported in multiple sclerosis (MS), systemic lupus erythematosus, male germinal epithelium, and highly replicating kidney tubule/bile duct cells.
- In MS, GANAB was upregulated in untreated relapsing-remitting MS patients compared with IFN-treated and other disease-modifying-therapy-treated patients, downregulated in treatment responders versus nonresponders, and higher in healthy controls than untreated RRMS patients; it correlated with lesion load, disease duration, and the Rio score.
- In autosomal dominant polycystic liver and kidney disease, GANAB mutations cause defective glucose trimming of N-glycan moieties and increased apparent molecular mass of polycystin-1; ADPLD genes explain only 25–30% of the genetic spectrum, and GANAB loss affects polycystin-1/polycystin-2 and cyst formation.
Methods
- Narrative review of glycobiology, GANAB/glucosidase II structure and function, unfolded protein response, and disease literature; no systematic review protocol or meta-analysis is described.
- Evidence is drawn from cited experimental, genetic, clinical, and animal studies; no primary data collection or new patient cohort is reported.
- Main analysis is a qualitative synthesis linking GANAB/N-glycan biology to human physiology and pathologies.
Limitations
- The authors state that glycomics knowledge is scattered and lacks a holistic/systematic view; for MS, no other published articles on GANAB were available to them; except for MS and polycystic kidney/liver disease, the relation between human pathology and α-glycosidases is only conceivable and not concretely demonstrated; more comprehensive studies are warranted.
- Evident from the text: as a narrative review, it lacks systematic search/selection criteria and formal quality assessment, so selection bias and reliance on heterogeneous evidence are possible.
- Evident from the text: conclusions often rest on animal or cell models and correlative human findings, so causality is not established.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
54 Valid · 22 Not valid · 70 Not checked · 43 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In addition, Glucosidase II is involved in human polycystic disease [8,9,10] and finally in the demyelinating ones of the central nervous system (CNS), according to the latest evidence [11].”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 1. Introduction
What the sources say
- Not checked — no full text of the sourcecites [8] Drenth J.P. te Morsche R.H. Smink R. Bonifacino J.S. Jansen J.B. Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease Nat. Genet. 2003 33 345 347 10.1038/ng1104 12577059 source
- Not checked — no full text of the sourcecites [9] Li A. Davila S. Furu L. Qian Q. Tian X. Kamath P.S. King B.F. Torres V.E. Somlo S. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease Am. J. Hum. Genet. 2003 72 691 703 10.1086/368295 12529853 PMC1180260 source
- Supportedcites [10] Porath B. Gainullin V.G. Cornec-Le Gall E. Dillinger E.K. Heyer C.M. Hopp K. Edwards M.E. Madsen C.D. Mauritz S.R. Banks C.J. Genkyst Study Group; HALT Progression of Polycystic Kidney Disease Group; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease; Harris, P.C. Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease Am. J. Hum. Genet. 2016 98 1193 1207 10.1016/j.ajhg.2016.05.004 27259053 PMC4908191 source
The Results identify GANAB as encoding the catalytic α subunit of glucosidase II and link mutations in the enzyme’s β subunit to polycystic liver disease. The paper’s title and figure legend also link GANAB mutations to affected people with kidney and liver cysts, supporting the broad claim that glucosidase II is involved in human polycystic disease. (LLM, conf=0.92)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“We know why partially glycosylated proteins have a shorter lifetime than fully glycosylated ones, due to the binding of galactose with hepatic asialoglycoprotein receptors expressed on hepatocytes, which promotes hepatic clearance of the partially glycosylated proteins [217].”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 6. Glycodrugs
What the sources say
- Supportedcites [217] Zhang L. Luo S. Zhang B. Glycan analysis of therapeutic glycoproteins MAbs 2016 8 205 215 10.1080/19420862.2015.1117719 26599345 PMC4966609 source
Split into 2 atoms — 2 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Many studies have found evidence of sustained and high-level activation of all three branches of the UPR (PERK, ATF6, IRE1α) in different tumors, including glioblastoma, MM, carcinomas of the breasts, stomach, esophagus, and liver [304,406,407,408,409].”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 9. UPR in Human Diseases: The Role of GII > 9.3. Cancer
What the sources say
- Not checked — no full text of the sourcecites [304] Shuda M. Kondoh N. Imazeki N. Tanaka K. Okada T. Mori K. Hada A. Arai M. Wakatsuki T. Matsubara O. Activation of the atf6, xbp1 and grp78 genes in human hepatocellular carcinoma: A possible involvement of the er stress pathway in hepatocarcinogenesis J. Hepatol. 2003 38 605 614 10.1016/S0168-8278(03)00029-1 12713871 source
- Partly supportedcites [406] Carrasco D.R. Sukhdeo K. Protopopova M. Sinha R. Enos M. Carrasco D.E. Zheng M. Mani M. Henderson J. Pinkus G.S. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis Cancer Cell 2007 11 349 360 10.1016/j.ccr.2007.02.015 17418411 PMC1885943 sourceExperimental — accuracy not yet measured
The Introduction reports elevated XBP-1 expression in multiple myeloma, breast tumors, and hepatocellular carcinomas, while the Discussion links sustained XBP-1s overexpression to myeloma development. The paper does not establish sustained, high-level activation of all three UPR branches in those tumors, or address that claim for glioblastoma, stomach, or esophageal carcinomas. Page numbers were not available in our copy. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [407] Fernandez P.M. Tabbara S.O. Jacobs L.K. Manning F.C. Tsangaris T.N. Schwartz A.M. Kennedy K.A. Patierno S.R. Overexpression of the glucose-regulated stress gene GRP78 in malignant but not benign human breast lesions Breast Cancer Res. Treat. 2000 59 15 26 10.1023/A:1006332011207 10752676 source
- Not checked — no full text of the sourcecites [408] Song M.S. Park Y.K. Lee J.H. Park K. Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-ε/ERK/AP-1 signaling cascade Cancer Res. 2001 61 8322 8330 11719466
- Not checked — no full text of the sourcecites [409] Chen X. Ding Y. Liu C.G. Mikhail S. Yang C.S. Overexpression of glucose-regulated protein 94 (Grp94) in esophageal adenocarcinomas of a rat surgical model and humans Carcinogenesis 2002 23 123 130 10.1093/carcin/23.1.123 11756233 source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Studies revealed that mutations in Prksch or Sec63 greatly reduce the expression, stability and proper trafficking of polycystin-1 (PC1), leading to cyst formation in a dose-dependent manner [426,427].”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 9. UPR in Human Diseases: The Role of GII > 9.5. ADPLD and ADPKD
What the sources say
- Not checked — no full text of the sourcecites [426] Waanders E. te Morsche R.H. de Man R.A. Jansen J.B. Drenth J.P. Extensive mutational analysis of PRKCSH and SEC63 broadens the spectrum of polycystic liver disease Hum. Mutat. 2006 27 830 10.1002/humu.9441 16835903 source
- Partly supportedcites [427] Hopp K. Ward C.J. Hommerding C.J. Nasr S.H. Tuan H.F. Gainullin V.G. Rossetti S. Torres V.E. Harris P.C. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity J. Clin. Investig. 2012 122 4257 4273 10.1172/JCI64313 23064367 PMC3484456 sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) links lower mature PC-1 dosage to more severe cystic disease, supporting the dose-dependent part of the claim. But the paper studies a Pkd1 variant, not mutations in Prksch or Sec63; its Figure 8 passage says the mutant PC-1 that reached urinary vesicles trafficked appropriately. It therefore does not establish the claimed effects of those two genes on PC-1 expression, stability, or trafficking. (LLM, conf=0.87)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“The level of functional PC1 at the cilium is thought to be central to the development of both hepatic and kidney cysts [428].”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 9. UPR in Human Diseases: The Role of GII > 9.5. ADPLD and ADPKD
What the sources say
- Supportedcites [428] Kim H. Xu H. Yao Q. Li W. Huang Q. Outeda P. Cebotaru V. Chiaravalli M. Boletta A. Piontek K. Ciliary membrane proteins traffic through the Golgi via a Rabep1/GGA1/Arl3-dependent mechanism Nat. Commun. 2014 5 5482 10.1038/ncomms6482 25405894 PMC4237283 source
The Discussion calls PC1 the central determinant of cyst formation in polycystic kidney and liver diseases and identifies it as the rate-limiting factor for ciliary trafficking of the polycystin complex. The paper also states that loss of polycystin function in cilia is implicated in cyst formation. Together, these support the citing sentence’s hedged claim. (LLM, conf=0.87)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
85 more claims · 26 with their cited sources checked
Create a free account to see all 189 claims and to verify the 17 references still open.
- It may state two separate claims as one. 56
- Probably not a substantial claim. 68
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 7. Protein Folding and Folding Quality Control Machinery > The UPR
“the α-GluI operates a first cleavage by removing a glucose residue from the conserved Glc2Man9GlcNAc2 N-linked glycan attached to nascent glycoprotein, and the resulting Glc1Man9GlcNAc2 glycan”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 7. Protein Folding and Folding Quality Control Machinery > The UPR
“ER-resident GluI and GluII sequentially trim the three terminal glucose moieties on N-linked Glc3Man9GlcNAc2 glycan coupled en bloc to nascent glycoproteins by oligosaccharyltransferase (OST)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 10. Conclusions
“the catalytic one is responsible for innermost glucose trimming on the Glc3Man9GlcNAc2 precursor signal. This reaction allows the nascent peptide to enter the CNX/CRT cycle for maturation.”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 9. UPR in Human Diseases: The Role of GII > 9.5. ADPLD and ADPKD
“The subsequent removal of the innermost glucose by GII allows for the exit of the protein, if properly folded. In this case, it can proceed along the secretory pathway.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 6. Glycodrugs > 6.3. Viral Infections and Glycodrugs
“The FDA-approved drug is called Relenza.”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 4. Recognition Patterns of Glycans
“the specific neuraminidase inhibitor zanamivir (Relenza) [103,104] projected onto the previously known sialidase inhibitor Neu5Ac2en [105]”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 8. The GANAB > 8.1. The Structure and Localization Glucosidase II
“the inner one exposes the Glc residue to the catalytic site on the GIIβ [369].”
§ GANAB and N-Glycans Substrates Are Relevant in Human Physiology, Polycystic Pathology and Multiple Sclerosis: A Review > 8. The GANAB > 8.1. The Structure and Localization Glucosidase II
“α-Glucosidase II (GluII or GII) consists of a 110 kDA catalytic α-subunit (GIIα) and 60 kDA regulatory β-subunit (GIIβ).”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“stress resulting in the induction of UPR, chaperones, and apoptotic markers [400,401].”
Cited work 10.1016/j.nbd.2008.02.009 · retracted 2020-12-25 · notice 10.1016/j.nbd.2020.105232 · this paper published 2022-07-01
Citations
Cites
1 retracted
Items 201–400 of 454
Audrézet, M.-P., Cornec-Le Gall, E., Chen, J.-M., Redon, S., Quéré, I., Creff, J., Bénech, C., Maestri, S., Le Meur, Y., & Férec, C. (2012) · Human Mutation · doi:10.1002/humu.22103 · Cited by 183 · cited 1×
“On the contrary, almost all ADPKD patients harbor gene mutations in polycystic kidney disease 1 (PKD1) or polycystic kidney disease 2 (PKD2) [431].”
BackgroundCaramelo, J. J., Castro, O. A., Alonso, L. G., de Prat-Gay, G., & Parodi, A. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262661199 · Cited by 183
NetCGlyc 1.0: Prediction of mammalian C-mannosylation sites
Julenius, K. (2007) · Glycobiology · doi:10.1093/glycob/cwm050 · Cited by 174 · cited 3×
“Numerous studies have shown that C-mannosylation is an important process in the secretion of proteins which are retained in the ER, if they do not undergo this type of glycosylation [176].”
BackgroundMethodInfluentialHughes, D., & Mallucci, G. R. (2019) · The FEBS Journal · doi:10.1111/febs.14422 · Cited by 174 · cited 1×
“BiP and PERK are upregulated in PD, also expressing cell loss as a common feature of chronic neuroinflammatory and neurodegenerative conditions [342].”
BackgroundDuman, J. G. (2015) · Journal of Experimental Biology · doi:10.1242/jeb.116905 · Cited by 173 · cited 1×
“This property is mediated by polysaccharides with a lipid component [29].”
BackgroundBenjamin, E. R., Flanagan, J. J., Schilling, A., Chang, H. H., Agarwal, L., Katz, E., Wu, X., Pine, C., Wustman, B., Desnick, R. J., et al. (2009) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-009-1077-0 · Cited by 173 · cited 2×
“Importantly, the chaperoning activity of Amigal®® is observed at concentrations that do not inhibit the α-Gal A or other galactosidases [236].”
BackgroundDeterminants of Glycosaminoglycan (GAG) Structure
Prydz, K. (2015) · Biomolecules · doi:10.3390/biom5032003 · Cited by 173 · cited 3×
“The structural flexibility and low-force interaction of the intrinsic negative charge with the extracellular matrix (ECM) components underlie this modulatory property and confer to them a quality of “plasticity” [36].”
Background(2001) · PubMed · Cited by 170
Jaeken, J., & Péanne, R. (2017) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-017-0050-6 · Cited by 170 · cited 1×
“ciated with hyper- or hypo-glycosylation [422].”
1,2,3‐Triazole hybrids with anti‐HIV‐1 activity
Feng, L., Zheng, M., Zhao, F., & Liu, D. (2021) · Archiv der Pharmazie · doi:10.1002/ardp.202000163 · Cited by 170 · cited 1×
“Benzyl 1,2,3-triazole derivatives, such as ribavirin, were found to inhibit the anti-HIV retroviral activity by 60–65%, at concentration of 50 μM, and then have been subjected to clinical evaluation [272].”
BackgroundRoach, T., Slater, S., Koval, M., White, L., McFarland, E. C., Okumura, M., Thomas, M., & Brown, E. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00188-6 · Cited by 169 · cited 1×
“Indeed, CD45 is thought to be an essential regulator of T and B cell antigen receptor signaling, working by the activation of Src family kinases and suppression of JAK kinases [387].”
BackgroundEndoplasmic reticulum associated protein degradation: A chaperone assisted journey to hell
Stolz, A., & Wolf, D. H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.02.005 · Cited by 169
UDP-GlC:glycoprotein glucosyltransferase-glucosidase II, the ying-yang of the ER quality control
D’Alessio, C., Caramelo, J. J., & Parodi, A. J. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.12.014 · Cited by 167 · cited 7×
“These enzymes are the A1 and A2 subunits of glutathione S-transferase, NAD(P)H:quinone oxidoreductase, γ-glutamylcysteine synthetase, Heme oxygenase-1 (HO-1) and UDP-glucoronosyl transferase [333].”
BackgroundInfluentialAdvanced glycation endproducts and its receptor for advanced glycation endproducts in obesity
Gaens, K. H., Stehouwer, C. D., & Schalkwijk, C. G. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32835aea13 · Cited by 166 · cited 2×
“The studies derived from these techniques evidence a net increased AGEs level in obesity [187], Diabetes Mellitus [207] and chronic inflammatory diseases, like Rheumatoid Arthritis [208], as well as in age-related diseases, such as cardiovascular, renal and neurodegenerative pathologies [193,209].”
BackgroundSialic acid recognition by Vibrio cholerae neuraminidase
Moustafa, I., Connaris, H., Taylor, M., Zaitsev, V., Wilson, J. C., Kiefel, M. J., von Itzstein, M., & Taylor, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404965200 · Cited by 165 · cited 1×
“The latter is the specific receptor for the B subunit of the AB5 choleric exotoxin [106].”
BackgroundRecent Advance in Tumor-associated Carbohydrate Antigens (TACAs)-based Antitumor Vaccines
Feng, D., Shaikh, A. S., & Wang, F. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00084 · Cited by 165
Endoplasmic reticulum stress in β-cells and development of diabetes
Fonseca, S. G., Burcin, M., Gromada, J., & Urano, F. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.07.003 · Cited by 157
Farach-Carson, M. C., Warren, C. R., Harrington, D. A., & Carson, D. D. (2014) · Matrix Biology · doi:10.1016/j.matbio.2013.08.004 · Cited by 155 · cited 1×
“These polymers are self-complexed with specific proteins, resulting in larger macromolecules generating structures such as basement membranes [30,31] and cartilage [32–34].”
BackgroundProteotoxicity in the endoplasmic reticulum: lessons from the Akita diabetic mouse
Ron, D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15020 · Cited by 155 · cited 1×
“In the Akita mice model of disease, the mice suffer from insufficient insulin production secondary to β-cell loss, reaching toxic gain-of-function, ER stress with apoptotic pathway activation, and frank diabetes within 4 to 5 weeks after birth [308,391].”
BackgroundFischer, P. B., Collin, M., Karlsson, G. B., James, W., Butters, T. D., Davis, S. J., Gordon, S., Dwek, R. A., & Platt, F. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5791-5797.1995 · Cited by 155 · cited 1×
“Nbutyl-DNJ and Celgosivir (6-O-butanoyl- castanospermine) have been shown to inhibit HIV infectivity in vitro by blocking viral envelope glycoprotein trimming [239,240].”
BackgroundO-GlcNAc and the Epigenetic Regulation of Gene Expression
Lewis, B. A., & Hanover, J. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.595439 · Cited by 153
Stavenhagen, K., Hinneburg, H., Thaysen‐Andersen, M., Hartmann, L., Silva, D. V., Fuchser, J., Kaspar, S., Rapp, E., Seeberger, P. H., & Kolarich, D. (2013) · Journal of Mass Spectrometry · doi:10.1002/jms.3210 · Cited by 153 · cited 1×
“In particular, the latter can be characterized by macroheterogeneity, referring to the site occupancy or completeness of glycosylation, while microheterogeneity concerns variations of glycan structure in a specific site compound [136,137].”
BackgroundProtein Folding in the Endoplasmic Reticulum and the Unfolded Protein Response
Zhang, K., & Kaufman, R. J. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-29717-0_3 · Cited by 152 · cited 21×
“After BiP dissociation, PERK and IRE1 are activated through oligomerization and autophosphorylation generating p-PERK and p-IRE1, respectively.”
BackgroundInfluentialVan Keimpema, L., De Koning, D. B., Van Hoek, B., Van Den Berg, A. P., Van Oijen, M. G. H., De Man, R. A., Nevens, F., & Drenth, J. P. H. (2011) · Liver International · doi:10.1111/j.1478-3231.2010.02247.x · Cited by 152 · cited 1×
“At present, genes responsible for ADPLD are PRKCSH, SEC63, SEC61B, GANAB, ALG8, DNAJB11 and ALG9, which only explain 25–30% of the genetic spectrum of disease [429,430].”
BackgroundStructural Basis for Catalysis and Inhibition ofN-Glycan Processing Class I α1,2-Mannosidases
Vallée, F., Karaveg, K., Herscovics, A., Moremen, K. W., & Howell, P. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006927200 · Cited by 152 · cited 1×
“Some iminosugars such as swainsonine [263], deoxymannojirimycin [264], castanospermine [265] have proved to be good inhibitors.”
BackgroundEndoplasmic Reticulum Stress and Diabetes Mellitus.
ARAKI, E., OYADOMARI, S., & MORI, M. (2003) · Internal Medicine · doi:10.2169/internalmedicine.42.7 · Cited by 151 · cited 1×
“high-level insulin secretion, β-cells undergo highly developed ER stress [305].”
BackgroundToxicity of advanced glycation end products (Review)
Kuzan, A. (2021) · Biomedical Reports · doi:10.3892/br.2021.1422 · Cited by 151
Pharmacokinetic and pharmacodynamic considerations in the development of therapeutic proteins
Mahmood, I., & Green, M. D. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544040-00001 · Cited by 150 · cited 1×
“It can influence pharmacokinetics also by protecting proteins from proteolytic degradation in vivo [216].”
BackgroundUse of polysialic acid in repair of the central nervous system
El Maarouf, A., Petridis, A. K., & Rutishauser, U. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608036103 · Cited by 150 · cited 1×
“In fact, due to both bulk and negative charges, hyaluronan and polysialic acid can inhibit cell–cell adhesion and cell–matrix interaction [37,38].”
BackgroundRecent Development in Carbohydrate-Based Cancer Vaccines
Guo, Z., & Wang, Q. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.08.010 · Cited by 149 · cited 2×
“Abbreviations α-Gal A α-galactosidase A; 18F-FDG glucose-analogue, 2-deoxy-2(18F)fluoro-D-glucose; 4-MU-Glc 4-methylunbelliferyl-a-D-glucopyranoside; AD Alzheimer’s disease; ADCC antibody-dependent cell-mediated cytotoxicity; ADCP antibody-dependent cellular phagocytosis; ADPKD Autosomal Dominant Polycystic Kidney Dis…”
BackgroundGlycosaminoglycan-Protein Interactions and Their Roles in Human Disease
Shi, D., Sheng, A., & Chi, L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.639666 · Cited by 148 · cited 1×
“Among these properties, the negative charge for all GAGs is paramount for their functions, and due to unknown reasons, positively charged glycans are uncommon in nature [15].”
BackgroundA sweet code for glycoprotein folding
Caramelo, J. J., & Parodi, A. J. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.07.021 · Cited by 146 · cited 12×
“In all cases, common aspects in the molecular physiology of UPR and ERAD suggest a therapeutic disease modifying approach, based on the inhibition of key mediators of apoptosis (such as CHOP, TXNIP, PERK and IRE1).”
BackgroundInfluentialKolb-Bachofen, V., Schlepper-Schäfer, J., Vogell, W., & Kolb, H. (1982) · Cell · doi:10.1016/0092-8674(82)90447-0 · Cited by 145 · cited 1×
“In fact, the loss of sialic acid from glycoproteins triggers clearance by the Kupffer cells carrying receptors for asialoglycoproteins [156].”
BackgroundFitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy
Das, S. R., Hensley, S. E., David, A., Schmidt, L., Gibbs, J. S., Puigbò, P., Ince, W. L., Bennink, J. R., & Yewdell, J. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108754108 · Cited by 143 · cited 1×
“However, larger glycans typically disrupt peptide loading on T-cell receptors (TCR) during the conjunction with the antigen processing cell [63], representing a common immune escape strategy of highly glycosylated enveloped viruses [64,65].”
BackgroundThe clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes
Sellner, J., Hemmer, B., & Mühlau, M. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.09.013 · Cited by 142 · cited 1×
“Molecular mimicry refers to the pathogenesis of many human pathologies such as demyelinating diseases such as MS [117] and Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders (NMO/NMOSD) [118,119], Bickerstaff’s brainstem encephalitis (BBE) [120], chronic inflammatory disease polyneuropathy (CIDP) [121] and o…”
BackgroundCelgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection.
Durantel, D. (2009) · PubMed · Cited by 139
Structural and Functional Analysis of the GADD34:PP1 eIF2α Phosphatase
Choy, M. S., Yusoff, P., Lee, I. C., Newton, J. C., Goh, C. W., Page, R., Shenolikar, S., & Peti, W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.043 · Cited by 139 · cited 1×
“p-eIF2α levels are tightly regulated by the protein phosphatase 1 (PP1) and growth arrest and DNA damage 34 (GADD34) complex, which quickly dephosphorylates p-eIF2α, preventing detrimental long-term global protein biosynthesis inhibition [327].”
BackgroundBurn, J. E., Hurley, U. A., Birch, R. J., Arioli, T., Cork, A., & Williamson, R. E. (2002) · The Plant Journal · doi:10.1046/j.1365-313x.2002.01483.x · Cited by 139 · cited 1×
“Consistently, no multicellular organism is known to survive GII knockout to adulthood [383], and also homozygous UGGT deletion is embryonically lethal in mice [384].”
BackgroundBurns, D. M., & Touster, O. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)33975-9 · Cited by 138 · cited 2×
“5% iodoacetamide were found to irreversibly inactivate the enzyme [372].”
BackgroundMethodPolycystin-1 maturation requires polycystin-2 in a dose-dependent manner
Gainullin, V. G., Hopp, K., Ward, C. J., Hommerding, C. J., & Harris, P. C. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76972 · Cited by 135
Natural and Synthetic Iminosugars as Carbohydrate Processing Enzyme Inhibitors for Cancer Therapy
Wrodnigg, T., Steiner, A., & Ueberbacher, B. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008783330851 · Cited by 134 · cited 2×
“Thus, swainsonine hydrochloride (GD0039) underwent clinical evaluation, but neither disease progression nor toxicity were not affected in the phase I trial [263].”
BackgroundDevelopments in Carbohydrate-Based Cancer Therapeutics
Hossain, F., & Andreana, P. R. (2019) · Pharmaceuticals · doi:10.3390/ph12020084 · Cited by 134 · cited 1×
“In particular, syalo mono-gangliosides (glycosphingolipids) GM2, GD2, and GD3 are involved in human melanomas and LeY, such as Sialyl Lewis A (sLeA), sLeX, sLeX-LeX, are human tumor-associated antigens [253].”
BackgroundProteotoxicity in the endoplasmic reticulum: Lessons from the Akita diabetic mouse
Ron, D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215020 · Cited by 133
van der Mech�, F. G. A., & van Doorn, P. A. (1995) · Annals of Neurology · doi:10.1002/ana.410370704 · Cited by 131 · cited 3×
“Sci. 2022, 23, 7373 31 of 49 DD disease duration; DMF Dimethyl Fumarate; DMT disease modifying therapy; DNJ 1-deoxynojirimycin; EAE experimental allergic encephalitis; ER endoplasmic reticulum; ERAD ER-associated degradation; ERGIC ER-Golgi intermediate compartment; FAD flavin adenine inucleotide; GADD34 growth arrest…”
BackgroundPolycystin-1: A master regulator of intersecting cystic pathways
Fedeles, S. V., Gallagher, A.-R., & Somlo, S. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.01.004 · Cited by 130 · cited 3×
“Treatment with proteasomal inhibitors increases levels of PC1 in cells by reversing the phenotype and providing a potential therapeutic approach [382].”
BackgroundThe Different Roles of Aggrecan Interaction Domains
Aspberg, A. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412464376 · Cited by 130
Ling, S. C. W., Lau, E. K. K., Al-Shabeeb, A., Nikolic, A., Catalano, A., Iland, H., Horvath, N., Ho, P. J., Harrison, S., Fleming, S., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.043331 · Cited by 130 · cited 2×
“Anyway, in this topic, we have of a proteasome inhibitor, Bortezomib.”
BackgroundThe Get1/2 transmembrane complex is an endoplasmic-reticulum membrane protein insertase
Wang, F., Chan, C., Weir, N. R., & Denic, V. (2014) · Nature · doi:10.1038/nature13471 · Cited by 129 · cited 1×
“In particular, Bat3, TRC35 and Ubl4A guide and facilitate the insertion of protein into the ER membrane with the aid of the Get1/2 receptor located on the ER-membrane [289].”
BackgroundGlycoscience: Biology and Medicine
(2015) · doi:10.1007/978-4-431-54841-6 · Cited by 129
Role of advanced glycation end products in carcinogenesis and their therapeutic implications
Schröter, D., & Höhn, A. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190130145549 · Cited by 126 · cited 1×
“Thus, some of the exogenous AGEs are carcinogenic, for example acrylamide or heterocyclic amines [198].”
BackgroundLiu, C. Y., Wong, H. N., Schauerte, J. A., & Kaufman, R. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112454200 · Cited by 124
Pelletier, M. F., Marcil, A., Sevigny, G., Jakob, C. A., Tessier, D. C., Chevet, E., Menard, R., Bergeron, J. J. M., & Thomas, D. Y. (2000) · Glycobiology · doi:10.1093/glycob/10.8.815 · Cited by 123 · cited 1×
“However, the co-expression of each isoform with the GIIβ in COS7 cells resulted in similar levels of enzyme activity [379].”
BackgroundSong, H., Qi, J., Khedri, Z., Diaz, S., Yu, H., Chen, X., Varki, A., Shi, Y., & Gao, G. F. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005411 · Cited by 122 · cited 1×
“Viral glycan-binding proteins (hemagglutinins) such as 9-O-acetyl ester on the sialic acid side chain of certain coronaviruses and influenza C and D viruses are critical for binding host cells [56,95,96].”
BackgroundTakeuchi, M., & Yamagishi, S.-I. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0974 · Cited by 121 · cited 4×
“There is also compelling evidence that non-TAGE molecules, such as CML, GO, MGO, pentosidine, pyrraline and crossline may be cytotoxic, with LD50 of CML calculated to be >5 mg/kg [194].”
BackgroundInfluentialMolinari, M., Galli, C., Vanoni, O., Arnold, S. M., & Kaufman, R. J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.09.027 · Cited by 121 · cited 1×
“Consistently, no multicellular organism is known to survive GII knockout to adulthood [383], and also homozygous UGGT deletion is embryonically lethal in mice [384].”
BackgroundZhou, A. X., & Tabas, I. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0372-x · Cited by 121 · cited 1×
“Moreover, in the atherosclerotic plaques, there is evidence of UPR activation [419].”
BackgroundEggermont, A. M. M., Suciu, S., Rutkowski, P. L., Marsden, J. R., Santinami, M., Corrie, P. G., Aamdal, S., Ascierto, P. A., Patel, P. M., Kruit, W. H. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.9303 · Cited by 118 · cited 1×
“Currently, some experimental vaccine therapeutics are approved, including GM2 KLH/QS-21 and MGV (GM2/GD2 KLH QS21) for malignant melanomas [257]; Theratope (sialyl-Tn Ag) for breast cancer [258]; IGN 301 (anti-idiotypic antibody) for LeY antigen associated with small cell lung cancer [259].”
BackgroundGlycosylphosphatidylinositol Anchors
Menon, A. K. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378630-2.00211-5 · Cited by 118
Cebon, J. S., Nicola, N. A., Ward, M. A., et al. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39589-4 · Cited by 116
The many functions of the endoplasmic reticulum chaperones and folding enzymes
Halperin, L., Jung, J., & Michalak, M. (2014) · IUBMB Life · doi:10.1002/iub.1272 · Cited by 116 · cited 7×
“This step causes the nascent protein to enter the folding CNX/CRT cycle.”
BackgroundInfluentialWu, R., Zhang, Q.-H., Lu, Y.-J., Ren, K., & Yi, G.-H. (2015) · DNA and Cell Biology · doi:10.1089/dna.2014.2552 · Cited by 116 · cited 1×
“Consistently, the silencing of each of these genes results in activation of at least the IRE1α/XBP1 branch of UPR [436].”
BackgroundTAGE (toxic AGEs) hypothesis in various chronic diseases
Takeuchi, M., & Yamagishi, S. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.02.042 · Cited by 116 · cited 2×
“The second group includes AGE-1 (glucose-derived AGEs), AGE-2 (glyceraldehyde-derived AGEs), AGE-3 (glycolaldehyde-derived AGEs), AGE-4 (GO/glyoxal, MGO/methylglyoxalderived AGEs), AGE-5 (glyoxal-derived AGEs), AGE-6 (3-deoxyglucosone-derived AGEs) and acetaldehyde-derived AGEs (AA-AGEs) [191].”
BackgroundCiliary membrane proteins traffic through the Golgi via a Rabep1/GGA1/Arl3-dependent mechanism
Kim, H., Xu, H., Yao, Q., Li, W., Huang, Q., Outeda, P., Cebotaru, V., Chiaravalli, M., Boletta, A., Piontek, K., et al. (2014) · Nature Communications · doi:10.1038/ncomms6482 · Cited by 114 · cited 1×
“The level of functional PC1 at the cilium is thought to be central to the development of both hepatic and kidney cysts [428].”
BackgroundSun, L., Huang, T., Dick, A., Meuser, M. E., Zalloum, W. A., Chen, C., Ding, X., Gao, P., Cocklin, S., Lee, K., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112085 · Cited by 113
Inflammatory-associated obstructions of the male reproductive tract
Dohle, G. R. (2003) · Andrologia · doi:10.1111/j.1439-0272.2003.tb00866.x · Cited by 113
Yoshimura, A., Zimmers, T., Neumann, D., Longmore, G., Yoshimura, Y., & Lodish, H. F. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49956-0 · Cited by 112 · cited 1×
“This also holds true for erythropoietin [180].”
Guillain-Barré syndrome and anti-ganglioside antibodies: A clinician-scientist’s journey
YUKI, N. (2012) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.88.299 · Cited by 109 · cited 3×
“Sci. 2022, 23, 7373 31 of 49 DD disease duration; DMF Dimethyl Fumarate; DMT disease modifying therapy; DNJ 1-deoxynojirimycin; EAE experimental allergic encephalitis; ER endoplasmic reticulum; ERAD ER-associated degradation; ERGIC ER-Golgi intermediate compartment; FAD flavin adenine inucleotide; GADD34 growth arrest…”
BackgroundWalz, A., Odenbreit, S., Mahdavi, J., Borén, T., & Ruhl, S. (2005) · Glycobiology · doi:10.1093/glycob/cwi049 · Cited by 109
Proinsulin Entry and Transit Through the Endoplasmic Reticulum in Pancreatic Beta Cells
Liu, M. R., Wright, J. J., Guo, H., Xiong, Y., & Arvan, P. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800174-5.00002-8 · Cited by 109 · cited 1×
“Moreover, preproinsulin is co-translationally translocated in the ER lumen, where its signal sequence is clipped off and subsequently transformed into proinsulin through the formation of three intramolecular disulfides by ER-resident oxidoreductases intervention that allow it to fold to its native shape [390].”
BackgroundReitman, M. L., Trowbridge, I. S., & Kornfeld, S. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34027-4 · Cited by 107 · cited 1×
“Regarding gene deletion studies, a lectin-resistant mutant cell line from mouse lymphoma was found to be deficient in GII activity [380].”
BackgroundCSF N-glycoproteomics for early diagnosis in Alzheimer's disease
Palmigiano, A., Barone, R., Sturiale, L., Sanfilippo, C., Bua, R. O., Romeo, D. A., Messina, A., Capuana, M. L., Maci, T., Le Pira, F., et al. (2016) · Journal of Proteomics · doi:10.1016/j.jprot.2015.10.006 · Cited by 107
Ashraf, J. M., Ahmad, S., Choi, I., Ahmad, N., Farhan, M., Tatyana, G., & Shahab, U. (2015) · IUBMB Life · doi:10.1002/iub.1450 · Cited by 106
Tropak, M. B., Blanchard, J. E., Withers, S. G., Brown, E. D., & Mahuran, D. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.12.006 · Cited by 105 · cited 1×
“A promising therapy for Tay–Sachs and Sandhoff diseases involves the use of β-Nacetylhexosaminidase inhibitors such as 2-acetamido-1,4-imino-1,2,4-tride-oxy-l-arabinitol (LABNAc) as a chemical chaperone to enhance the enzyme activity above subcritical levels in order to avoid glycolipid storage [237].”
BackgroundMechanism of Endoplasmic Reticulum Stress in Cerebral Ischemia
Han, Y., Yuan, M., Guo, Y.-S., Shen, X.-Y., Gao, Z.-K., & Bi, X. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.704334 · Cited by 105 · cited 1×
“Finally, brain regions affected by stroke also show ER stress-induced apoptosis [421].”
BackgroundHINCUTs in cancer: Hypoxia-induced noncoding ultraconserved transcripts
Ferdin, J., Nishida, N., Wu, X., Nicoloso, M. S., Shah, M. Y., Devlin, C., Ling, H., Shimizu, M., Kumar, K., Cortez, M. A., et al. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.119 · Cited by 103 · cited 1×
“Furthermore, it has been proposed that hypoxia-upregulated transcribed-ultra conserved regions (T-UCR), named hypoxia-induced noncoding ultra-conserved transcript (HINCUT), are critical for the optimal O-GlcNAcylation of proteins in oxygen deprivation in cancer [152].”
BackgroundMolecular Mimicry in Multiple Sclerosis
Libbey, J. E., McCoy, L. L., & Fujinami, R. S. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(07)79006-2 · Cited by 102 · cited 1×
“Molecular mimicry refers to the pathogenesis of many human pathologies such as demyelinating diseases such as MS [117] and Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders (NMO/NMOSD) [118,119], Bickerstaff’s brainstem encephalitis (BBE) [120], chronic inflammatory disease polyneuropathy (CIDP) [121] and o…”
BackgroundGopal, S., Mikulskis, A., Gold, R., Fox, R. J., Dawson, K. T., & Amaravadi, L. (2017) · Multiple Sclerosis Journal · doi:10.1177/1352458517690617 · Cited by 102 · cited 7×
“Sci. 2022, 23, 7373 32 of 49 PERK pancreatic endoplasmic reticulum kinase; PET positron emission tomography; PG peptidoglycan; pNP-Glc p-nitrophenyl-a-D-glucopyranoside; PP1 protein phosphatase 1; PQC protein quality control; PRKCSH protein kinase C substrate 80 K-H; Pro proline; PRR pattern recognition receptors; PSA…”
BackgroundInfluentialClinical Use of Digitalis: A State of the Art Review
Whayne, T. F. (2018) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-018-0292-1 · Cited by 99 · cited 1×
“Digoxin, instead, is a purified cardiac glycoside found in the foxglove plant Digitalis lanata, expressing same biological activity and is conventionally used for the treatment of atrial fibrillation and flutter [267].”
BackgroundKeum, Y., Han, Y., Liew, C. V., Kim, J. H., Xu, C., Yuan, X., Shakarjian, M. P., Chong, S., & Kong, A. T. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9094-2 · Cited by 98 · cited 1×
“These enzymes are the A1 and A2 subunits of glutathione S-transferase, NAD(P)H:quinone oxidoreductase, γ-glutamylcysteine synthetase, Heme oxygenase-1 (HO-1) and UDP-glucoronosyl transferase [333].”
BackgroundChapter 14 Cerebral vascular dysregulation in the ischemic brain
(2008) · Handbook of Clinical Neurology · doi:10.1016/s0072-9752(08)01914-3 · Cited by 98 · cited 1×
“When blood flow is restored, reperfusion of affected tissues leads to oxidative stress and alterations in the redox state of the ER that disrupt the protein disulfide formation and cause ER protein misfolding [417,418].”
BackgroundIsolation of a homogeneous glucosidase II from pig kidney microsomes
BRADA, D., & DUBACH, U. C. (1984) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1984.tb08169.x · Cited by 97 · cited 3×
“Regarding GII activators, 10 mM Man (172% activation), 50 mM Isomaltose (142% activation), and starch (7 mg/mL, 160% activation) activate the enzyme isolated from pig kidney microsomes [371].”
BackgroundMethodPERK-opathies: An Endoplasmic Reticulum Stress Mechanism Underlying Neurodegeneration
C. Bell, M., E. Meier, S., L. Ingram, A., & F. Abisambra, J. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666151218145431 · Cited by 97
Selective Inactivation of Influenza C Esterase: A Probe for Detecting 9- O -Acetylated Sialic Acids
Muchmore, E. A., & Varki, A. (1987) · Science · doi:10.1126/science.3589663 · Cited by 96
Dekan, G., Gabel, C., & Farquhar, M. G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5398 · Cited by 96
Post-Synthetic Regulation of HS Structure: The Yin and Yang of the Sulfs in Cancer
Vivès, R. R., Seffouh, A., & Lortat-Jacob, H. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2013.00331 · Cited by 95
Al-Sadi, R., Engers, J., Haque, M., King, S., Al-Omari, D., & Ma, T. Y. (2021) · PLOS ONE · doi:10.1371/journal.pone.0249544 · Cited by 93 · cited 1×
“Thus, the complex signaling pathway is constituted by the sequence of selectins, chemokines and integrins at the interface blood/CNS, resulting in emperipolesis through matrix metalloproteinases type 9 (MMP9) activation and tight-junctions disruption [74,75].”
BackgroundN-glycoprotein macroheterogeneity: biological implications and proteomic characterization
Zacchi, L. F., & Schulz, B. L. (2015) · Glycoconjugate Journal · doi:10.1007/s10719-015-9641-3 · Cited by 93 · cited 1×
“In particular, the latter can be characterized by macroheterogeneity, referring to the site occupancy or completeness of glycosylation, while microheterogeneity concerns variations of glycan structure in a specific site compound [136,137].”
BackgroundChronic inflammatory demyelinating polyneuropathy as an autoimmune disease
Rodríguez, Y., Vatti, N., Ramírez-Santana, C., Chang, C. C.-C., Páez, O. M., Gershwin, M. E., & Anaya, J. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.04.021 · Cited by 93 · cited 1×
“Molecular mimicry refers to the pathogenesis of many human pathologies such as demyelinating diseases such as MS [117] and Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders (NMO/NMOSD) [118,119], Bickerstaff’s brainstem encephalitis (BBE) [120], chronic inflammatory disease polyneuropathy (CIDP) [121] and o…”
BackgroundFischl, M. A., Resnick, L., Coombs, R. W., Kremer, A. B., Pottage, J. C., Fass, R. J., Fife, K. H., Powderly, W. G., Collier, A. C., & Aspinall, R. L. (1994) · PubMed · Cited by 92
Munro, S. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00302-5 · Cited by 92 · cited 1×
“The mature protein contains two EF-Hand motifs (Ca2+ binding loops), an acidic stretch of consecutive glutamic acids, several cysteine residues at the NH2 and COOH terminals [360], MRH domain, and a COOH- terminal HDEL sequence for ER retention/retrieval [367].”
BackgroundTinkering with heparan sulfate sulfation to steer development
Gorsi, B., & Stringer, S. E. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.02.006 · Cited by 91
Gao, K., Zheng, C., Wang, T., Zhao, H., Wang, J., Wang, Z., Zhai, X., Jia, Z., Chen, J., Zhou, Y., et al. (2016) · Molecules · doi:10.3390/molecules21111600 · Cited by 91 · cited 1×
“Furthermore, the anti-cancer effect is due to the GANAB inhibition, affecting enhanced glycoprotein turnover, which is reflected by an extremely active lysosomal system and membrane trafficking in tumors [226].”
BackgroundGlycoprotein Quality Control and Endoplasmic Reticulum Stress
Wang, Q., Groenendyk, J., & Michalak, M. (2015) · Molecules · doi:10.3390/molecules200813689 · Cited by 90 · cited 1×
“However, in the presence of high levels of unfolded/misfolded proteins in the ER, BiP dissociates from the N-terminus of ER stress transducers, leading to UPR activation [321].”
BackgroundCnossen, W. R., te Morsche, R. H. M., Hoischen, A., Gilissen, C., Chrispijn, M., Venselaar, H., Mehdi, S., Bergmann, C., Veltman, J. A., & Drenth, J. P. H. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309438111 · Cited by 90 · cited 1×
“The only exception is the LRP5, a transmembrane protein, part of the LRP5/LRP6/Frizzled co-receptor complex in the canonical Wnt signaling pathway [425].”
BackgroundFujimoto, T., Onda, M., Nagai, H., Nagahata, T., Ogawa, K., & Emi, M. (2003) · Breast Cancer · doi:10.1007/bf02967649 · Cited by 90
Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity
Chen, G.-Y., Brown, N. K., Zheng, P., & Liu, Y. (2014) · Glycobiology · doi:10.1093/glycob/cwu068 · Cited by 90 · cited 1×
“In particular, surface sialoglycans provide a mechanism to allow the host to discriminate between infectious non-self from non-infectious self [116].”
BackgroundNew Applications of Heparin and Other Glycosaminoglycans
Lima, M., Rudd, T., & Yates, E. (2017) · Molecules · doi:10.3390/molecules22050749 · Cited by 89 · cited 3×
“The anticoagulant activity is mediated by the activating antithrombin III (a serine protease inhibitor), which, in turn, blocks thrombin, thereby inhibiting blood coagulation factors, Xa and IIa [268].”
BackgroundInfluentialA unique role for 6-O sulfation modification in zebrafish vascular development
Chen, E., Stringer, S. E., Rusch, M. A., Selleck, S. B., & Ekker, S. C. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.05.032 · Cited by 88
Therapeutic applications of iminosugars: Current perspectives and future opportunities
Horne, G., & Wilson, F. X. (2011) · Progress in medicinal chemistry · doi:10.1016/b978-0-12-381290-2.00004-5 · Cited by 87 · cited 1×
“Iminosugars, where a nitrogen replaces the endocyclic oxygen atom in the hemiaminal ring system of structure, are another important class of carbohydrates with medicinal properties and are also common components of plants [219].”
BackgroundWang, X.-Q., Sun, P., & Paller, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308818200 · Cited by 87
Springer, S. A., Diaz, S. L., & Gagneux, P. (2014) · Immunogenetics · doi:10.1007/s00251-014-0795-0 · Cited by 87 · cited 1×
“Specifically, N-Glycolylneuraminic acid (Neu5Gc) is a sialic acid, a lack of which, in males, leads to higher fertilization rates, and, on the contrary, to lower rates in females [54].”
BackgroundSyndecans in cartilage breakdown and synovial inflammation
Pap, T., & Bertrand, J. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.178 · Cited by 86
C-mannosylation supports folding and enhances stability of thrombospondin repeats
Shcherbakova, A., Preller, M., Taft, M. H., Pujols, J., Ventura, S., Tiemann, B., Buettner, F. F., & Bakker, H. (2019) · eLife · doi:10.7554/elife.52978 · Cited by 85
Inhibition of formation of complex oligosaccharides by the glucosidase inhibitor bromoconduritol
Datema, R., Romero, P. A., Legler, G., & Schwarz, R. T. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.22.6787 · Cited by 84 · cited 1×
“Finally, Bromoconduritol (6-bromo-3,4,5-trihydroxycyclohex-1-ene) inhibits the removal of the innermost α1,3-linked glucose residue from Glc2Man9GlcNAc2, leading to the accumulation of unprocessed high-mannose N-glycans in treated cells [378].”
Background6–0-Butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVs
Taylor, D. L., Sunkara, P. S., Liu, P. S., Kang, M. S., Bowlin, T. L., & Tyms, A. S. (1991) · AIDS · doi:10.1097/00002030-199106000-00008 · Cited by 84 · cited 1×
“Nbutyl-DNJ and Celgosivir (6-O-butanoyl- castanospermine) have been shown to inhibit HIV infectivity in vitro by blocking viral envelope glycoprotein trimming [239,240].”
BackgroundThe PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases
Rozpędek-Kamińska, W., Siwecka, N., Wawrzynkiewicz, A., Wojtczak, R., Pytel, D., Diehl, J. A., & Majsterek, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062108 · Cited by 84
COOPER, T. G., YEUNG, C. H., NASHAN, D., JOCKENHÖVEL, F., & NIESCHLAG, E. (1990) · International Journal of Andrology · doi:10.1111/j.1365-2605.1990.tb01035.x · Cited by 83
Subedi, G. P., Hanson, Q. M., & Barb, A. W. (2014) · Structure · doi:10.1016/j.str.2014.08.002 · Cited by 81 · cited 1×
“It is now evident that nucleocytoplasmic glycosylation functionally characterizes many proteins according to an allosteric mechanism [76].”
BackgroundChen, X. (2002) · Carcinogenesis · doi:10.1093/carcin/23.1.123 · Cited by 81
Structural analysis of the glycosylation of gene-activated erythropoietin (epoetin delta, Dynepo)
Llop, E., Gutiérrez-Gallego, R., Segura, J., Mallorquí, J., & Pascual, J. A. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.08.027 · Cited by 79
Unfolded protein stress in the endoplasmic reticulum and mitochondria: a role in neurodegeneration
Bernales, S., Soto, M. M., & McCullagh, E. (2012) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2012.00005 · Cited by 78 · cited 1×
“Interestingly, dj1 is dysregulated in PD and upregulated in peripheral blood mononuclear cells (PBMCs) from MS [328,351].”
BackgroundMapping posttranscriptional regulation of the human glycome uncovers microRNA defining the glycocode
Agrawal, P., Kurcon, T., Pilobello, K. T., Rakus, J. F., Koppolu, S., Liu, Z., Batista, B. S., Eng, W. S., Hsu, K.-L., Liang, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321524111 · Cited by 77 · cited 1×
“The glycosylation regulated by glyco-miRNAs provides a link between miRNA-mediated control of cell phenotype and cellular glycanic compounds [150].”
BackgroundRoles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection
Kobayashi, M., Lee, H., Nakayama, J., & Fukuda, M. N. (2009) · Glycobiology · doi:10.1093/glycob/cwp004 · Cited by 76
PERK Pathway and Neurodegenerative Disease: To Inhibit or to Activate?
Shacham, T., Patel, C., & Lederkremer, G. Z. (2021) · Biomolecules · doi:10.3390/biom11030354 · Cited by 76 · cited 1×
“Not by chance, PERK, GADD34, ATF6 α, eIF2α and CHOP are considered promising therapeutic targets for myelin disorders and other chronic inflammatory or degenerative organ specific diseases [328,331].”
BackgroundCation-independent Mannose 6-Phosphate Receptor
Bohnsack, R. N., Song, X., Olson, L. J., Kudo, M., Gotschall, R. R., Canfield, W. M., Cummings, R. D., Smith, D. F., & Dahms, N. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056184 · Cited by 75 · cited 2×
“Abbreviations α-Gal A α-galactosidase A; 18F-FDG glucose-analogue, 2-deoxy-2(18F)fluoro-D-glucose; 4-MU-Glc 4-methylunbelliferyl-a-D-glucopyranoside; AD Alzheimer’s disease; ADCC antibody-dependent cell-mediated cytotoxicity; ADCP antibody-dependent cellular phagocytosis; ADPKD Autosomal Dominant Polycystic Kidney Dis…”
BackgroundYan, L. Z., & Dawson, P. E. (2001) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20011001)40:19<3693::aid-anie3693>3.0.co;2-o · Cited by 75
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
Hossain, M., & Wall, K. (2016) · Vaccines · doi:10.3390/vaccines4030025 · Cited by 74
Koch, B. E., Stougaard, J., & Spaink, H. P. (2015) · Glycobiology · doi:10.1093/glycob/cwv005 · Cited by 72 · cited 1×
“homopolymers of glucose for cellulose and N-acetylglucosamine for chitin are the most abundant organic molecules on the planet, providing structures such as plant and fungal cell walls and arthropod exoskeletons [23,24].”
BackgroundGardiner, E. E., De Luca, M., McNally, T., Michelson, A. D., Andrews, R. K., & Berndt, M. C. (2001) · Blood · doi:10.1182/blood.v98.5.1440 · Cited by 72 · cited 1×
“P-selectins can bind to the plasmalemmal sLeX on the neutrophils in the bloodstream, helping the extravasation of these cells during infection [168], but also the mononuclear cells during tethering and rolling over the BBB in the early phase of neuroinflammation detected in MS and related disorders [169].”
Backgroundvan der Goot, A. T., Pearce, M. M. P., Leto, D. E., Shaler, T. A., & Kopito, R. R. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.03.026 · Cited by 72 · cited 1×
“Man7GlcNAc2 form of N-glycans generated after GluI and GluII activity is recognized by lectins OS9 and XTP3-B, which contain one and two mannose 6-phosphate receptor homology (MRH) domains, respectively [355].”
BackgroundThe role of MRH domain-containing lectins in ERAD
Hosokawa, N., Kamiya, Y., & Kato, K. (2010) · Glycobiology · doi:10.1093/glycob/cwq013 · Cited by 71 · cited 12×
“In all cases, common aspects in the molecular physiology of UPR and ERAD suggest a therapeutic disease modifying approach, based on the inhibition of key mediators of apoptosis (such as CHOP, TXNIP, PERK and IRE1).”
BackgroundInfluentialThe structure of moranoline, a piperidine alkaloid from Morus species.
Masaaki, Y. A. G. I., Kouno, T., AOYAGI, Y., & Murai, H. (1976) · Cited by 71
Structural Features of the αβTCR Mechanotransduction Apparatus That Promote pMHC Discrimination
Brazin, K. N., Mallis, R. J., Das, D. K., Feng, Y., Hwang, W., Wang, J.-H., Wagner, G., Lang, M. J., & Reinherz, E. L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00441 · Cited by 70 · cited 1×
“However, larger glycans typically disrupt peptide loading on T-cell receptors (TCR) during the conjunction with the antigen processing cell [63], representing a common immune escape strategy of highly glycosylated enveloped viruses [64,65].”
BackgroundChapman, P. B., Wu, D., Ragupathi, G., Lu, S., Williams, L., Hwu, W.-J., Johnson, D., & Livingston, P. O. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0345 · Cited by 70 · cited 1×
“Thus, GD3 ganglioside vaccines and anti-idiotypic monoclonal antibodies, which mimic GD3 gangliosides, were carried out on melanoma patients with evidence of a low survival outcome [256].”
BackgroundMicrosomal Glucosidases of Rat Liver. Partial Purification and Inhibition by Disaccharides
UGALDE, R. A., STANELONI, R. J., & LELOIR, L. F. (2005) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06144.x · Cited by 68
Patsos, G., Hebbe-Viton, V., Robbe-Masselot, C., Masselot, D., Martin, R. S., Greenwood, R., Paraskeva, C., Klein, A., Graessmann, M., Michalski, J. C., et al. (2009) · Glycobiology · doi:10.1093/glycob/cwn149 · Cited by 68 · cited 1×
“Here, the C-1 of N-acetylgalactosamine is covalently bonded to the hydroxyl of serine or threonine of the nascent core protein [158,159].”
BackgroundPhosphoglycosylation: A new structural class of glycosylation?
Haynes, P. A. (1998) · Glycobiology · doi:10.1093/glycob/8.1.1 · Cited by 67
Stavenhagen, K., Hinneburg, H., Thaysen‐Andersen, M., Hartmann, L., Silva, D. V., Fuchser, J., Kaspar, S., Rapp, E., Seeberger, P. H., & Kolarich, D. (2013) · Journal of Mass Spectrometry · doi:10.1002/jms.3189 · Cited by 66
Extensive mutational analysis ofPRKCSH andSEC63 broadens the spectrum of polycystic liver disease
Waanders, E., te Morsche, R. H. M., de Man, R. A., Jansen, J. B. M. J., & Drenth, J. P. H. (2006) · Human Mutation · doi:10.1002/humu.9441 · Cited by 64 · cited 1×
“Studies revealed that mutations in Prksch or Sec63 greatly reduce the expression, stability and proper trafficking of polycystin-1 (PC1), leading to cyst formation in a dose-dependent manner [426,427].”
BackgroundMalpede, B. M., Lin, D. H., & Tolia, N. H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.450643 · Cited by 63
Treml, K., Meimaroglou, D., Hentges, A., & Bause, E. (2000) · Glycobiology · doi:10.1093/glycob/10.5.493 · Cited by 63 · cited 2×
“GIIα clones isolated from a human liver cDNA library encoded two distinct enzyme isoforms that differed in a 66 bp insertion, suggesting alternative splicing [363].”
BackgroundAutoantibody to MOG suggests two distinct clinical subtypes of NMOSD
Yan, Y., Li, Y., Fu, Y., Yang, L., Su, L., Shi, K., Li, M., Liu, Q., Borazanci, A., Liu, Y., et al. (2016) · Science China Life Sciences · doi:10.1007/s11427-015-4997-y · Cited by 63
ILG, T., HARBECKE, D., WIESE, M., & OVERATH, P. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18283.x · Cited by 62
McCormack, P. L., & Goa, K. L. (2003) · Drugs · doi:10.2165/00003495-200363220-00006 · Cited by 62
Kiss, Z., Elliott, S. G., Jedynasty, K., Tesař, V., & Szegedi, J. (2010) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0780-y · Cited by 61
Ramprasad, J., Sthalam, V. K., Thampunuri, R. L. M., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126671 · Cited by 61
van Eupen, M. G. A., Schram, M. T., Colhoun, H. M., Hanssen, N. M. J., Niessen, H. W. M., Tarnow, L., Parving, H. H., Rossing, P., Stehouwer, C. D. A., & Schalkwijk, C. G. (2013) · Diabetologia · doi:10.1007/s00125-013-2919-8 · Cited by 60 · cited 1×
“The studies derived from these techniques evidence a net increased AGEs level in obesity [187], Diabetes Mellitus [207] and chronic inflammatory diseases, like Rheumatoid Arthritis [208], as well as in age-related diseases, such as cardiovascular, renal and neurodegenerative pathologies [193,209].”
BackgroundImino sugars are potent agonists of the human glucose sensor SGLT3
Voss, A. A., Díez-Sampedro, A., Hirayama, B. A., Loo, D. D. F., & Wright, E. M. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.030288 · Cited by 59 · cited 1×
“Interestingly, DNJ and Miglitol were found to be potent agonists of the human glucose sensor, sodium/glucose cotransporter type 3 [234].”
BackgroundInhibition of sialidase activity as a therapeutic approach
Glanz, V. Y., Myasoedova, V. A., Grechko, A. V., & Orekhov, A. N. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s176220 · Cited by 59 · cited 1×
“The neuraminic acid glycomimetic Neu5Ac2en, other than iminosugar, inhibits sialidases by altering transition state analogue, resulting in neuraminidase inhibitor, thus working in treatment and prophylaxis of influenza A and B [244].”
BackgroundUgalde, R. A., Staneloni, R. J., & Leloir, L. F. (1978) · FEBS Letters · doi:10.1016/0014-5793(78)81174-0 · Cited by 59
Revisiting the glomerular charge barrier in the molecular era
Harvey, S. J., & Miner, J. H. (2008) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e32830464de · Cited by 58 · cited 1×
“Main examples of this property are represented by podocalyxin on glomerular podocyte [67–69] and heparan sulfate glycosaminoglycans on the glomerular basement membrane [70,71].”
BackgroundSatoh, T., Toshimori, T., Yan, G., Yamaguchi, T., & Kato, K. (2016) · Scientific Reports · doi:10.1038/srep20575 · Cited by 58 · cited 1×
“Trimming two inner glucoses α1,3-Glc and α1,2-Glc from protein bound precursors produces, respectively, the Glc2Man9GlcNAc2-Asn as well as the Glc1Man9GlcNAc2-Asn and Man9GlcNAc2-Asn structures [357].”
Jacob, J. R., Mansfield, K. G., You, J. E., Tennant, B. C., & Kim, Y. H. (2007) · PubMed · Cited by 57
Vivas‐Acevedo, G., Lozano‐Hernández, R., & Camejo, M. I. (2013) · British Journal of Urology · doi:10.1111/bju.12523 · Cited by 57 · cited 1×
“Few articles deal with GII activity and male infertility, particularly deriving from epididymal pathology, such as varicocele and epididymitis [437,438].”
BackgroundMechanisms of FGF gradient formation during embryogenesis
Balasubramanian, R., & Zhang, X. (2016) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.10.004 · Cited by 56
Carbohydrate-Based Vaccines: An Overview
Hütter, J., & Lepenies, B. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2874-3_1 · Cited by 55 · cited 1×
“Other carbohydrate-based vaccines approved to date include the ActHiB, OmniHiB (Haemophilus b) for Influenzae type b; Typhoid Vi (Typhim Vi) for Typhoid fever; and Prevnar (pneumococcal conjugate Pneumonia caused by Streptococcus vaccine) for pneumonia [271].”
BackgroundArendt, C. W., & Ostergaard, H. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13117 · Cited by 55 · cited 1×
“An in vitro association between CD45 (a transmembrane protein-tyrosine phosphatase, PTP) and αglucosidase II has been reported in SAKR mouse T-lymphocyte cell line [386].”
BackgroundUnfolded protein response in myelin disorders
Lin, W., & Stone, S. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.266903 · Cited by 55 · cited 3×
“Interestingly, dj1 is dysregulated in PD and upregulated in peripheral blood mononuclear cells (PBMCs) from MS [328,351].”
BackgroundHirai, M., & Shimizu, N. (1990) · Biochemical Journal · doi:10.1042/bj2700583 · Cited by 54 · cited 1×
“It was first identified as a protein kinase C substrate 80 K-H (PRKCSH) by Hirai and Shimizu in 1990 [359] and determined as a part of the heterodimeric complex in 1996 by Trombetta and coworkers [360], finally as a Glc removing factor from protein precursor in 1999 by Herscovics and in 2002 by Trombetta and Parodi [3…”
BackgroundCongenital disorders of glycosylation in hepatology: The example of polycystic liver disease
Janssen, M. J., Waanders, E., Woudenberg, J., Lefeber, D. J., & Drenth, J. P. H. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.011 · Cited by 54 · cited 8×
“In fact, although ADPLD and ADPKD are two distinct genetic disorders, they share PLD as a major phenotypic feature.”
BackgroundInfluentialGlycosylation-modified erythropoietin with improved half-life and biological activity
Su, D., Zhao, H., & Xia, H. (2010) · International Journal of Hematology · doi:10.1007/s12185-010-0496-x · Cited by 53
Studies on the structure of a phosphoglycoprotein from the parasitic protozoan Trypanosoma cruzi
Ferguson, M. A. J., Allen, A. K., & Snary, D. (1983) · Biochemical Journal · doi:10.1042/bj2130313 · Cited by 53 · cited 1×
“This refers to xylose in Trypanosoma cruzi [183].”
BackgroundFerhati, X., Matassini, C., Fabbrini, M. G., Goti, A., Morrone, A., Cardona, F., Moreno-Vargas, A. J., & Paoli, P. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.03.053 · Cited by 53 · cited 2×
“This modification confers a particularly high affinity for the α-glucosidase enzyme inhibition, resulting in a clinically relevant anti-diabetic effect [230,231].”
BackgroundGao, H., Wang, Y., Wegierski, T., Skouloudaki, K., Pütz, M., Fu, X., Engel, C., Boehlke, C., Peng, H., Kuehn, E. W., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp463 · Cited by 52 · cited 6×
“Sci. 2022, 23, 7373 31 of 49 DD disease duration; DMF Dimethyl Fumarate; DMT disease modifying therapy; DNJ 1-deoxynojirimycin; EAE experimental allergic encephalitis; ER endoplasmic reticulum; ERAD ER-associated degradation; ERGIC ER-Golgi intermediate compartment; FAD flavin adenine inucleotide; GADD34 growth arrest…”
BackgroundInfluentialGene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus
Deng, Y. J., Huang, Z. X., Zhou, C. J., Wang, J. W., You, Y., Song, Z. Q., Xiang, M. M., Zhong, B. Y., & Hao, F. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2005.07.039 · Cited by 51 · cited 1×
“In 2006, Deng and coworkers attempted to characterize gene expression of CD4+ T lymphocytes in patients suffering from this disease [446].”
BackgroundSchwartz, P. M., Shipman, C., & Drach, J. C. (1976) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.10.1.64 · Cited by 49 · cited 1×
“Vidarabine, an arabinosyl nucleoside analogue, first intended as anticancer drug, has been marketed as an antiviral drug against infections caused by herpes simplex and varicella zoster viruses [281].”
BackgroundCarbohydrate-Based Therapeutics
Mishra, S., Upadhaya, K., Mishra, K. B., Shukla, A. K., Tripathi, R. P., & Tiwari, V. K. (2016) · Studies in natural products chemistry · doi:10.1016/b978-0-444-63601-0.00010-7 · Cited by 49
Deficits in Sialylation Impair Podocyte Maturation
Weinhold, B., Sellmeier, M., Schaper, W., Blume, L., Philippens, B., Kats, E., Bernard, U., Galuska, S. P., Geyer, H., Geyer, R., et al. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011090947 · Cited by 48
Sampath, C., Zhu, Y., Sang, S., & Ahmedna, M. (2016) · Phytomedicine · doi:10.1016/j.phymed.2015.12.013 · Cited by 48
You are what you eat: O-linked N-acetylglucosamine in disease, development and epigenetics
Olivier-Van Stichelen, S., & Hanover, J. A. (2015) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0000000000000188 · Cited by 48
An Integrated Three-Long Non-coding RNA Signature Predicts Prognosis in Colorectal Cancer Patients
Liu, Y., Liu, B., Jin, G., Zhang, J., Wang, X., Feng, Y., Bian, Z., Fei, B., Yin, Y., & Huang, Z. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01269 · Cited by 48 · cited 1×
“For example, long intervening/intergenic noncoding RNAs (lincRNAs) have been linked to O-glycosylation involved in CRC progression [151].”
BackgroundHettkamp, H., Bause, E., & Legler, G. (1982) · Bioscience Reports · doi:10.1007/bf01114896 · Cited by 48 · cited 2×
“Turanose (Ki 19 mM) was also found to inhibit enzymes from pig kidneys [373].”
BackgroundMethodIto, M., Sugihara, K., Asaka, T., Toyama, T., Yoshihara, T., Furuichi, K., Wada, T., & Asano, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029873 · Cited by 47
Barfeld, S. J., East, P., Zuber, V., & Mills, I. G. (2014) · BMC Medical Genomics · doi:10.1186/s12920-014-0074-9 · Cited by 47 · cited 1×
“Regarding prostate cancer, a net molecular signature suggests a prevalence of glycosylation enzymes with a missense variant rs61752561 resulting in prostate specific antigen (PSA) extra glycosylation as well as other somatic variants causing the potential loss of glycosylation [142].”
BackgroundBickerstaff brainstem encephalitis with or without anti-GQ1b antibody
Yoshikawa, K., Kuwahara, M., Morikawa, M., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000889 · Cited by 47
Herrmann, K., Benz, M., Krause, B. J., Pomykala, K. L., Buck, A. K., & Czernin, J. (2011) · PubMed · Cited by 46
Allan, G., Ouadid-Ahidouch, H., Sanchez-Fernandez, E. M., Risquez-Cuadro, R., Fernandez, J. M. G., Ortiz-Mellet, C., & Ahidouch, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076411 · Cited by 45 · cited 1×
“Some iminosugars such as swainsonine [263], deoxymannojirimycin [264], castanospermine [265] have proved to be good inhibitors.”
BackgroundHamaguchi, J., Nakagawa, H., Takahashi, M., Kudo, T., Kamiyama, N., Sun, B., Oshima, T., Sato, Y., Deguchi, K., Todo, S., et al. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-58 · Cited by 45
Carbohydrate Immune Adjuvants in Subunit Vaccines
Bashiri, S., Koirala, P., Toth, I., & Skwarczynski, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100965 · Cited by 45 · cited 1×
“As for anticancer vaccines, carbohydrates also play a twofold key role for antimicrobial vaccines, providing the specificity of the immune response against pathogen and immunogenicity [269].”
BackgroundResveratrol, curcumin and gallic acid attenuate glyoxal-induced damage to rat renal cells
Hashemzaei, M., Tabrizian, K., Alizadeh, Z., Pasandideh, S., Rezaee, R., Mamoulakis, C., Tsatsakis, A., Skaperda, Z., Kouretas, D., & Shahraki, J. (2020) · Toxicology Reports · doi:10.1016/j.toxrep.2020.11.008 · Cited by 44
Scher, M. G., & Waechter, C. J. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30118-7 · Cited by 44
Cabezas, J. A., Reglero, Á., & Calvo, P. (1983) · International Journal of Biochemistry · doi:10.1016/0020-711x(83)90087-3 · Cited by 42 · cited 1×
“Viral neuraminidases are glycosidases (sialidases precisely) that hydrolyze the neuraminic acid present in animal tissue and bacteria during the infectious phase when the receptor bridging to the host cell takes place by elimination of the steric hindrance induced by the surrounding sialic acid on the glycocalyx [243].”
BackgroundWalter, S., Fassbender, K., Gulbins, E., Liu, Y., Rieschel, M., Herten, M., Bertsch, T., & Engelhardt, B. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00308-9 · Cited by 41
MELLOR, H. R., NEVILLE, D. C. A., HARVEY, D. J., PLATT, F. M., DWEK, R. A., & BUTTERS, T. D. (2004) · Biochemical Journal · doi:10.1042/bj20031824 · Cited by 41 · cited 1×
“Suspended in water-soluble fractions of plants and microbial broths, iminosugars seem likely to be synthetized to protect carbohydrates produced during photosynthesis and to reduce competition from other microorganisms by inhibiting their glycosidases [222].”
BackgroundAGE-induced neuronal cell death is enhanced in G2019S LRRK2 mutation with increased RAGE expression
Cho, H. J., Xie, C., & Cai, H. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0106-z · Cited by 41
Martiniuk, F., Ellenbogen, A., & Hirschhorn, R. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)71234-2 · Cited by 41
ALI, H. B., GUERIN, J. F., PINATEL, M. C., MATHIEU, C., BOULIEU, D., & TRITAR, B. (1994) · International Journal of Andrology · doi:10.1111/j.1365-2605.1994.tb01230.x · Cited by 41 · cited 1×
“In fact, GII activity is significantly reduced when an inflammatory occlusion distally to the epididymis occurs [440–442], in the case of functional deficiency of the latter in non-azoospermic patients [443], as well as a poor ability to bind the zona pellucida, thus suggesting a role of the enzyme also in sperm–egg b…”
BackgroundWhy do we determine alpha-glucosidase activity in human semen during infertility work-up?
Krause, W. K. H., & Bohring, C. (1999) · Andrologia · doi:10.1046/j.1439-0272.1999.00285.x · Cited by 41
Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology?
Azevedo, R., Peixoto, A., Gaiteiro, C., Fernandes, E., Neves, M., Lima, L., Santos, L. L., & Ferreira, J. A. (2017) · Oncotarget · doi:10.18632/oncotarget.19433 · Cited by 39
ALONSO, J. M., SANTA‐CECILIA, A., & CALVO, P. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18004.x · Cited by 38 · cited 1×
“However, the kinetic reaction of these compounds is experimentally different, being immediate for the former, intermediate for the second, and slow for the third, reflecting, respectively, the step of entry in the maturation process, the linkage of chaperones, and finally the release of the latter, starting the secret…”
BackgroundFlura, T., Brada, D., Ziak, M., & Roth, J. (1997) · Glycobiology · doi:10.1093/glycob/7.5.617 · Cited by 37 · cited 1×
“Cells accumulated glycoproteins containing Glc2-1Man9-8GlcNAc2 glycans, also expressing the complete loss of GII activity in vitro [381].”
BackgroundSodium–glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class
da Silva, P. N., da Conceição, R. A., Maia, R. D. C., & Barbosa, M. L. D. C. (2018) · MedChemComm · doi:10.1039/c8md00183a · Cited by 37 · cited 3×
“Derivative fluorodapagliflozins have been synthesized by introducing a high-electronwithdrawing difluoro substituent, which decreases the negative charge of oxygen in the structure ring, resulting in better affinity with SGLT2 [277].”
BackgroundLei, Z., Yue, Y., Stone, S., Wu, S., & Lin, W. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1156-20.2020 · Cited by 37 · cited 1×
“In vitro and in vivo studies have shown that activation of the PERK-eIF2α pathway leads to activation of NF-κB in oligodendrocytes and suggest neuroprotective effects of PERK signaling in MS and experimental allergic encephalitis (EAE), which is the animal model of MS [330].”
BackgroundAquaporin 4 molecular mimicry and implications for neuromyelitis optica
Vaishnav, R. A., Liu, R., Chapman, J., Roberts, A. M., Ye, H., Rebolledo-Mendez, J. D., Tabira, T., Fitzpatrick, A. H., Achiron, A., Running, M. P., et al. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.04.015 · Cited by 36 · cited 1×
“Molecular mimicry refers to the pathogenesis of many human pathologies such as demyelinating diseases such as MS [117] and Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders (NMO/NMOSD) [118,119], Bickerstaff’s brainstem encephalitis (BBE) [120], chronic inflammatory disease polyneuropathy (CIDP) [121] and o…”
BackgroundBugg, T. D. H., Rodolis, M. T., Mihalyi, A., & Jamshidi, S. (2016) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2016.03.018 · Cited by 36 · cited 1×
“Nucleosides have an inhibitory effect over phospho-MurNAc-pentapeptide translocase, resulting in a biosynthesis block of the peptidoglycan layer [247].”
BackgroundSorbera (2005) · doi:10.1358/dof.2005.030.06.914820 · Cited by 36 · cited 2×
“Celgosivir has also been shown to have a 30-fold greater antiviral activity than the parent compound against cytomegalovirus, influenza and HCV [225,241].”
BackgroundSong, H., Qi, J., Khedri, Z., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005505 · Cited by 36
The evolution of the dystroglycan complex, a major mediator of muscle integrity
Adams, J. C., & Brancaccio, A. (2015) · Biology Open · doi:10.1242/bio.012468 · Cited by 35 · cited 1×
“Given the highly conserved form of alpha dystroglycan from vertebrates to mammals, the severe human dystrophies induced by its mutations are not surprising [186].”
BackgroundWurzer, W. J., Obojes, K., & Vlasak, R. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-2-395 · Cited by 35 · cited 1×
“This refers to the flu virus and vibrio cholerae [100].”
BackgroundGlucosidase II and MRH-Domain Containing Proteins in the Secretory Pathway
D’Alessio, C., & Dahms, N. M. (2015) · Current Protein and Peptide Science · doi:10.2174/1389203716666150213160438 · Cited by 34 · cited 1×
“The primary structure of GII presents overlapping sequences with several other glucosidases as well as MRH domain, but not with glucosidase I [368].”
BackgroundTwo distinct domains of the -subunit of glucosidase II interact with the catalytic -subunit
Arendt, C., & Ostergaard, H. L. (2000) · Glycobiology · doi:10.1093/glycob/10.5.487 · Cited by 34 · cited 3×
“ular, two non-overlapping interaction domains, ID1 and ID2, have been identified [364].”
BackgroundInfluentialStow, J. L., Soroka, C. J., Mackay, K., Striker, L. J., Striker, G., & Farquhar, M. G. (1989) · PubMed · Cited by 33
Matkowski, A., Miroliaei, M., Aminjafari, A., Ślusarczyk, S., Nawrot-Hadzik, I., & Rahimmalek, M. (2017) · Pharmacognosy Magazine · doi:10.4103/pm.pm_559_16 · Cited by 33 · cited 1×
“In the first classification system, the most extensively studied AGEs are N-carboxymethyllysine (CML), pentosidine, crossline, pyrraline and hydroimidazolone [190].”
BackgroundCoupling of Cerebral Metabolism and Blood Flow in Epileptic Seizures, Hypoxia and Hypoglycaemia
Nilsson, B., Rehncrona, S., & Siesjö, B. K. (1978) · Novartis Foundation Symposia · doi:10.1002/9780470720370.ch11 · Cited by 33 · cited 1×
“Reduced blood flow as a result of arterial occlusion or hypotension causes tissue hypoxia and hypoglycemia [415].”
BackgroundHolzer, S., Rzechorzek, N. J., Short, I. R., Jenkyn-Bedford, M., Pellegrini, L., & Kilkenny, M. L. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00367 · Cited by 33 · cited 1×
“Vidarabine triphosphate directly inhibits DNA polymerase, also acting as chain terminator in DNA replication [282].”
BackgroundNiu, L., Heaney, M. L., Vera, J. C., & Golde, D. W. (2000) · Blood · doi:10.1182/blood.v95.11.3357 · Cited by 32
Ihara, Y., Manabe, S., Ikezaki, M., Inai, Y., Matsui, I.-S. L., Ohta, Y., Muroi, E., & Ito, Y. (2010) · Glycobiology · doi:10.1093/glycob/cwq096 · Cited by 32 · cited 1×
“Only in 2011 was the first C-mannosylated protein determined using crystallography, the human complement component 8 [177].”
MethodGrünblatt, E., Nemoda, Z., Werling, A. M., Roth, A., Angyal, N., Tarnok, Z., Thomsen, H., Peters, T., Hinney, A., Hebebrand, J., et al. (2019) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32695 · Cited by 32 · cited 1×
“LRP5 also seems to be involved in PC1 disfunction, having recently been recognized as a coreceptor for Wnt noncanonical signaling pathway [435].”
BackgroundImpact of sialyltransferase ST6GAL1 overexpression on different colon cancer cell types
Venturi, G., Gomes Ferreira, I., Pucci, M., Ferracin, M., Malagolini, N., Chiricolo, M., & Dall’Olio, F. (2019) · Glycobiology · doi:10.1093/glycob/cwz053 · Cited by 32
Impact of glycosylation on the unimpaired functions of the sperm
Cheon, Y., & Kim, C. (2015) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2015.42.3.77 · Cited by 32 · cited 1×
“Although the exact role played byα-glucosidase in sperm function is not well understood, it can be speculated that the enzyme is responsible for sperm differentiation through protein modification and maturation [439].”
Background
Research works printed but not linked: 8
- Varki A. Schauer R. Sialic Acids Essentials of Glycobiology 2nd ed. Varki A. Cummings R.D. Esko J.D. Freeze H.H. Stanley P. Bertozzi C.R. Hart G.W. Etzler M.E. Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY, USA 2009 Chapter 14 Available online: https://www.ncbi.nlm.nih.gov/books/NBK1920/ (accessed on 28 February 2022)
- Taylor M.E. Drickamer K. Introduction to Glycobiology 2nd ed. Oxford University Press Oxford, UK 2006
- Varki A. Cummings R. Esko J. Freeze H.H. Stanley P. Bertozzi C.R. Hart G.W. Etzler M.E. Essentials of Glycobiology Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY, USA 1999 Chapter 16 Available online: https://www.ncbi.nlm.nih.gov/books/NBK20705/ (accessed on 28 February 2022) 20301239
- Stanley P. Schachter H. Taniguchi N. N-Glycans Essentials of Glycobiology Varki A. Cummings R.D. Esko J.D. Freeze H.H. Stanley P. Bertozzi C.R. Hart G.W. Etzler M.E. Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY, USA 2009 101 114
- Voet D. Voet J.G. Pratt C.W. Fundamentals of Biochemistry John Wiley & Sons, Inc. Hoboken, NJ, USA 1999
- Brockhausen I. Schachter H. Stanley P. O-GalNAc Glycans Essentials of Glycobiology 2nd ed. Varki A. Cummings R.D. Esko J.D. Freeze H.H. Stanley P. Bertozzi C.R. Hart G.W. Etzler M.E. Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY, USA 2009 Chapter 9 20301232
- Zachara N. Akimoto Y. Hart G.W. The O-GlcNAc Modification Essentials of Glycobiology 3rd ed. Varki A. Cummings R.D. Esko J.D. Freeze H.H. Stanley P. Bertozzi C.R. Hart G.W. Etzler M.E. Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY, USA 2017 Chapter 19 Available online: https://www.ncbi.nlm.nih.gov/books/NBK453063/ (accessed on 28 February 2022) 10.1101/glycobiology.3e.01 · doi:10.1101/glycobiology.3e.01
- Janeway C.A. Jr. Travers P. Walport M. Walport M. Shlomchik M.J. Antigen receptor structure and signaling pathways Immunobiology: The Immune System in Health and Disease 5th ed. Garland Science New York, NY, USA 2001 Available online: https://www.ncbi.nlm.nih.gov/books/NBK27130/ (accessed on 28 February 2022)
Cited by
Multi-scale signaling and tumor evolution in high-grade gliomas
Liu, J., Cao, S., Imbach, K. J., Gritsenko, M. A., Lih, T. M., Kyle, J. E., Yaron-Barir, T. M., Binder, Z. A., Li, Y., Strunilin, I., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.06.004 · Cited by 81
Ramaprabha, K., Kumar, S. V., Saravanan, P., Rajeshkannan, R., Rajasimman, M., Kamyab, H., & Vasseghian, Y. (2023) · Environmental Research · doi:10.1016/j.envres.2023.117521 · Cited by 91
Xue, X., Wu, X., Liu, L., Liu, L., & Zhu, F. (2023) · Viruses · doi:10.3390/v15061298 · Cited by 15
Withana, M., & Castorina, A. (2023) · Cells · doi:10.3390/cells12222633 · Cited by 12
“Post-mortem analyses of human CNS tissues have demonstrated the presence of activated IRE1 α and UPR in patients with Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (ALS) [47].”
BackgroundSoloveva, N. A., Novikova, S. E., Farafonova, T. E., Tikhonova, O. V., & Zgoda, V. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031016 · Cited by 10
Metadata
- Authors
- De Masi, R., & Orlando, S.
- Affiliations
- Complex Operative Unit of Neurology, “F. Ferrari” Hospital, Casarano, 73042 Lecce, Italy
- Laboratory of Neuroproteomics, Multiple Sclerosis Centre, “F. Ferrari” Hospital, Casarano, 73042 Lecce, Italy
- Corresponding author
- Orlando, Stefania
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-07-01
- Volume
- 23
- Issue
- 13
- Pages
- 7373
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9266668
- OpenAlex
- W4283802200
- Cited by
- 20
- References
- 464
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 3 · 2023: 5
- FWCI
- 0.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- GANAB, N-glycans, N-acetyl-beta-D-glucosaminidase, polycystic kidney disease, polycystic liver disease, multiple sclerosis, unfolded protein response, polycystin-1, polycystin-2, protein folding, glycosylation, ATF6, PERK, IRE1, BiP, systemic lupus erythematosus, cyst formation
- MeSH terms
- Glucose, Humans, Male, Multiple Sclerosis, Polysaccharides, TRPP Cation Channels, Unfolded Protein Response
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.